Oxidative stress from DGAT1 oncoprotein inhibition in melanoma suppresses tumor growth when ROS defenses are also breached
Authors
Wilcock, D. J.Badrock, A. P.
Wong, C. W.
Owen, R.
Guerin, M.
Southam, A. D.
Johnston, H.
Telfer, B. A.
Fullwood, P.
Watson, J.
Ferguson, H.
Ferguson, J.
Lloyd, G. R.
Jankevics, A.
Dunn, W. B.
Wellbrock, C.
Lorigan, Paul C
Ceol, C.
Francavilla, C.
Smith, M. P.
Hurlstone, A. F. L.
Affiliation
Division of Cancer Studies, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PT, UKIssue Date
2022
Metadata
Show full item recordAbstract
Dysregulated cellular metabolism is a cancer hallmark for which few druggable oncoprotein targets have been identified. Increased fatty acid (FA) acquisition allows cancer cells to meet their heightened membrane biogenesis, bioenergy, and signaling needs. Excess FAs are toxic to non-transformed cells but surprisingly not to cancer cells. Molecules underlying this cancer adaptation may provide alternative drug targets. Here, we demonstrate that diacylglycerol O-acyltransferase 1 (DGAT1), an enzyme integral to triacylglyceride synthesis and lipid droplet formation, is frequently up-regulated in melanoma, allowing melanoma cells to tolerate excess FA. DGAT1 over-expression alone transforms p53-mutant zebrafish melanocytes and co-operates with oncogenic BRAF or NRAS for more rapid melanoma formation. Antagonism of DGAT1 induces oxidative stress in melanoma cells, which adapt by up-regulating cellular reactive oxygen species defenses. We show that inhibiting both DGAT1 and superoxide dismutase 1 profoundly suppress tumor growth through eliciting intolerable oxidative stress.Citation
Wilcock DJ, Badrock AP, Wong CW, Owen R, Guerin M, Southam AD, et al. Oxidative stress from DGAT1 oncoprotein inhibition in melanoma suppresses tumor growth when ROS defenses are also breached. Vol. 39, Cell Reports. Elsevier BV; 2022. p. 110995.Journal
Cell ReportsDOI
10.1016/j.celrep.2022.110995PubMed ID
35732120Additional Links
https://dx.doi.org/10.1016/j.celrep.2022.110995Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.celrep.2022.110995
Scopus Count
Collections
Related articles
- Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress.
- Authors: Cheng X, Geng F, Pan M, Wu X, Zhong Y, Wang C, Tian Z, Cheng C, Zhang R, Puduvalli V, Horbinski C, Mo X, Han X, Chakravarti A, Guo D
- Issue date: 2020 Aug 4
- Role of diacylglycerol O-acyltransferase (DGAT) isoforms in bovine hepatic fatty acid metabolism.
- Authors: Yang W, Wang S, Loor JJ, Lopes MG, Zhao Y, Ma X, Li M, Zhang B, Xu C
- Issue date: 2022 Apr
- Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes.
- Authors: de la Rosa Rodriguez MA, Deng L, Gemmink A, van Weeghel M, Aoun ML, Warnecke C, Singh R, Borst JW, Kersten S
- Issue date: 2021 May
- Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5.
- Authors: Mitra R, Le TT, Gorjala P, Goodman OB Jr
- Issue date: 2017 Sep 6
- Hepatic synthesis of triacylglycerols containing medium-chain fatty acids is dominated by diacylglycerol acyltransferase 1 and efficiently inhibited by etomoxir.
- Authors: Wunderling K, Leopold C, Jamitzky I, Yaghmour M, Zink F, Kratky D, Thiele C
- Issue date: 2021 Mar